General Meetings

Annual General Meeting
The Annual General Meeting (AGM) is the decision-making body for BioInvent at which all shareholders can participate. The AGM considers the Company's progress and resolves on a number of key issues such as dividends, Directors fees, amendments to the Articles of Association, appointing auditors, discharge of the Board of Directors from liability, and the election of a new Board of Directors until the next Annual General Meeting. The auditor is appointed every four years, as is the remuneration for the auditor.

Notification to attend the AGM is published no earlier than six, and no later than four, weeks before the Meeting.

To have a matter dealt with at the meeting, shareholders must submit a written request to the Board well in advance although no later than seven weeks prior to the Annual Meeting if the matter is to be included on the agenda.